Learn about why delayed hemolysis occurs, how it can affect newborns diagnosed with HDFN and how it can be treated.

Hemolysis is the #1 source of preanalytical error and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary ...

A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the ...

Learn more about the potential benefits of delayed umbilical cord clamping, including increased blood flow and improved iron ...

Patients with T2D are at higher risk for adverse pregnancy outcomes like preeclampsia, preterm birth, and neonatal ...

Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...

Simulating the Shear Destruction of Red Blood Cells Nov. 1, 2022 — The destruction of red blood cells, or mechanical hemolysis, is an inevitable complication of interventional devices ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data from the BEACON Phase 1/2 clinical trial of BEAM- ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report) today and set a price target of ...

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...

Methods Braided stents were developed using poly-L-lactic acid fibers with material surface area similar to metal flow diverters. Crush resistance force, hemolysis, and thrombogenicity were determined ...